Description: Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Home Page: www.akiliinteractive.com
AKLI Technical Analysis
125 Broad Street
Boston,
MA
02110
United States
Phone:
617 456 0597
Officers
| Name | Title |
|---|---|
| Dr. Walter Edward Martucci Ph.D. | Co-Founder, CEO & Director |
| Dr. Adam Gazzaley M.D., Ph.D. | Co-founder, Chief Science Advisor & Director |
| Mr. Santosh Shanbhag | CFO & Treasurer |
| Ms. Jacqueline L. Studer J.D. | Chief Legal Officer, Gen. Counsel & Sec. |
| Mr. Matthew Franklin M.B.A. | Pres & COO |
| Mr. Matthew Omernick | Co-Founder & Chief Creative Officer |
| Mr. Carl Gottlieb | Chief Technology Officer |
| Ms. Julie DiCarlo | Sr. VP of Communications |
| Ms. Barrie Brian | Sr. VP of People |
| Dr. Scott H. Kollins Ph.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9749 |
| Price-to-Sales TTM: | 323.7493 |
| IPO Date: | 2022-08-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 143 |